Market News for Astrazeneca Plc spons Adr (AZN)
Drugmakers or countries that strike pricing deals or make manufacturing investment commitments in the U.S. can secure much lower levies, or none at all....
WSJ - 4/2/2026 5:34:00 PM
More News for AZN
Stock Analysis for AZN
Related Stocks:
AstraZeneca said on Thursday that a combination treatment with its cancer drug Imfinzi showed significant improvement in how long patients with a common liver cancer lived before their disease worsened, in a late-stage trial....
Reuters - 4/2/2026 6:47:12 AM
More News for AZN
Stock Analysis for AZN
Related Stocks:
AstraZeneca reports phase III data showing efzimfotase alfa improves bone health in children with HPP, with mixed adult results and an overall favorable safety profile....
Zacks Investment Research - 4/1/2026 12:05:57 PM
More News for AZN
Stock Analysis for AZN
Related Stocks:
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has reported mixed phase three trial data for efzimfotase alfa, its treatment for hypophosphatasia, a rare genetic disease that impairs the body's ability to mineralise bones and teeth. Results from the paediatric trials, known as MULBERRY and CHESTNUT, were positive, but the HICKORY trial in adults and adolescents produced a more complicated picture....
Proactive Investors - 4/1/2026 9:20:34 AM
More News for AZN
Stock Analysis for AZN
Related Stocks:
